A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Renal Cell Carcinoma|Breast Cancer|Colon Cancer|Lung Cancer|Non-Hodgkin Lymphoma
Interventions: DRUG: DMS 612
Sponsor: National Cancer Institute (NCI)